For decades, lighting design was based on the assumption that the human visual system was the sole recipient of light. As a result, lighting quality was assessed through parameters such as illuminance (lx), color rendering index (CRI), unified glare rating (UGR), and uniformity.
The breakthrough came in the early 21st century with the discovery of a third class of retinal photoreceptors: intrinsically photosensitive retinal ganglion cells (ipRGCs). These cells contain melanopsin and are not responsible for vision itself but rather for transmitting light information to the suprachiasmatic nucleus (SCN), the body's central biological clock.
This discovery fundamentally changed our understanding of the role of light. It became clear that the human body responds not only to the amount of light required for vision, but also to its spectral composition, timing, direction of incidence, and variability throughout the day.
In response to these scientific findings, the International Commission on Illumination (CIE) published the standard CIE S 026/E:2018, introducing a framework for evaluating the biological impact of light using melanopic quantities. Today, this document serves as one of the most important references for lighting design that considers circadian effectiveness.
This represents a fundamental shift in design philosophy. Traditional lighting standards answer the question:
“Can the user see properly?”
Modern lighting design must also ask:
“Does the lighting environment support healthy physiological functioning?”